Detection of First Relapse in Cutaneous Melanoma Patients: Implications for the Formulation of Evidence-Based Follow-up Guidelines

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Annals of Surgical Oncology

• Publication date

  2007-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-007-9347-2PMID 17357855
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma

  2006cited by this paper
• Multiple primary melanomas: Implications for screening and follow-up programs for melanoma

  2006cited by this paper
• Follow-up in patients with localised primary cutaneous melanoma.

  2005cited by this paper
• Acceptability and feasibility of a community-based screening programme for melanoma in Australia.

  2004cited by this paper
• Surveillance and Follow-up Examinations in Cutaneous Melanoma

  2003cited by this paper
• Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy.

  2003cited by this paper
• The new melanoma staging system.

  2002cited by this paper
• Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients

  2002influential reference
• Primary staging and follow-up in melanoma patients – monocenter evaluation of methods, costs and patient survival

  2002cited by this paper
• Compliance with follow-up and prognosis among patients with thin melanomas.

  2001cited by this paper
• New melanoma staging system

  2001influential reference
• Delays in diagnosis and melanoma prognosis (I): The role of patients

  2000cited by this paper
• Patterns of detection in patients with cutaneous melanoma

  2000influential reference
• Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma

  1999cited by this paper
• Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment

  1999cited by this paper
• A rational approach to melanoma follow‐up in patients with primary cutaneous melanoma

  1999cited by this paper
• Is physician detection associated with thinner melanomas?

  1999cited by this paper
• Multiple primary melanomas.

  1998cited by this paper
• Follow-up requirements for thick cutaneous melanoma.

  1997cited by this paper
• Recurrence of thin melanoma: how effective is follow-up?

  1996cited by this paper
• Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas.

  1995cited by this paper
• Melanoma recurrence surveillance. Patient or physician based?

  1995cited by this paper
• Cost-effectiveness of surveillance of stage I melanoma. A retrospective appraisal based on a 10-year experience in a dermatology department in France.

  1995cited by this paper
• Multiple Primary Melanomas: Data and Significance

  1995cited by this paper
• First Recurrence Analysis of 840 Cutaneous Melanomas: A Proposal for a Follow-Up Schedule

  1994cited by this paper
• Follow-up in stage I cutaneous malignant melanoma: an audit.

  1993cited by this paper
• Who detects the first recurrence in stage I cutaneous malignant melanoma: patient or doctor? 156

  1993cited by this paper
• First recurrence analysis of 840 cutaneous melanomas: a proposal for a follow-up schedule.

  1993cited by this paper
• Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study.

  1988cited by this paper
• Malignant melanoma, evaluation of clinical follow up by questionnaire survey.

  1987cited by this paper
• The value of staging and serial follow‐up investigations in patients with completely resected, primary, cutaneous malignant melanoma

  1985cited by this paper

• Employing skin self-examination and fear of cancer recurrence management in early-stage melanoma follow-up: evaluation of the MELACARE intervention in a randomised controlled trial.

  2025cites this paper
• Engagement in and correlates of total cutaneous exams and skin self-exams among young melanoma survivors and their family

  2025cites this paper
• Barriers and facilitators to skin cancer prevention among Hispanics: a qualitative study

  2024cites this paper
• Associations of Social Factors and Self-Efficacy with Skin-Self Examination Intentions Among Hispanics at Risk for Skin Cancer and Their Preferences for Digital Interventions

  2024cites this paper
• A Digital Intervention to Improve Skin Self-Examination Among Survivors of Melanoma: Protocol for a Type-1 Hybrid Effectiveness-Implementation Randomized Trial

  2024cites this paper
• Service implications of the revised 2022 National Institute for Health and Care Excellence (NICE) follow-up guidelines for stage IA–IIC melanoma

  2024cites this paper
• Stage IIA Cutaneous Melanoma: Do Regional Ultrasound and CT scan Improve Detection of Relapses? A Multicenter Retrospective Observational Study

  2024cites this paper
• Genital Pigmented Lesions

  2023cites this paper
• Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients

  2023cites this paper
• Melanoma - risk factors and prevention strategies

  2023cites this paper
• Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis.

  2022cites this paper
• The role of surveillance imaging for resected high‐risk melanoma

  2022cites this paper
• Digital Educational Strategies to Teach Skin Self-examination to Individuals at Risk for Skin Cancer

  2022cites this paper
• Follow-up Schedule for Patients With Sentinel Node–negative Cutaneous Melanoma (The MELFO Study)

  2022cites this paper
• Moderators of the Effects of mySmartSkin, a Web-Based Intervention to Promote Skin Self-examination and Sun Protection Among Individuals Diagnosed With Melanoma.

  2022cites this paper
• The significance of imaging examinations during follow-up for malignant melanoma

  2021cites this paper
• Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model.

  2021cites this paper
• Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical Trial.

  2021cites this paper
• Evidence-Based Screening for Recurrence

  2021cites this paper
• Pembrolizumab in the adjuvant treatment of melanoma: efficacy and safety

  2021cites this paper
• mySmartCheck, a Digital Intervention to Promote Skin Self-examination Among Individuals Diagnosed With or at Risk for Melanoma: A Randomized Clinical Trial.

  2021cites this paper
• Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies

  2021cites this paper
• El paciente superviviente al cáncer en la consulta de atención primaria

  2020cites this paper
• Late Metastatic Melanoma after 25 Years: A Case Report and a Brief Literature Review

  2020cites this paper
• Diagnosis and management of cutaneous melanoma.

  2020cites this paper
• Das maligne Melanom - ein Überblick

  2020influential citation
• Analyzing Controversies in Management and Surveillance of Early-Stage Melanoma

  2020cites this paper
• ASO Author Reflections: The MelFo-Study, UK: Effects of a Reduced Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma IB–IIC Patients After 3 Years

  2020cites this paper
• The MelFo Study UK: Effects of a Reduced-Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma 1B to 2C Patients After 3-Years

  2020cites this paper
• Time from incident primary cancer until recurrence or second primary cancer: Risk factors and impact in general practice.

  2019cites this paper
• The MELFO Study: A Multicenter, Prospective, Randomized Clinical Trial on the Effects of a Reduced Stage-Adjusted Follow-Up Schedule on Cutaneous Melanoma IB–IIC Patients—Results After 3 Years

  2019cites this paper
• Surveillance and Follow-Up of Melanoma Patients

  2019cites this paper
• Patients' Views About Skin Self-examination After Treatment for Localized Melanoma.

  2019cites this paper
• False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma

  2019cites this paper
• Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma: study design and baseline characteristics.

  2019cites this paper
• Healthcare utilisation in general practice and hospitals in the year preceding a diagnosis of cancer recurrence or second primary cancer: a population-based register study

  2019cites this paper
• The role of routine imaging in pediatric cutaneous melanoma

  2018cites this paper
• Follow‐up of the melanoma patient

  2018cites this paper
• Patient Preferences for Follow-up After Recent Excision of a Localized Melanoma

  2018influential citation
• Use of shared care and routine tests in follow-up after treatment for localised cutaneous melanoma

  2018cites this paper
• Follow-Up Recommendations after Diagnosis of Primary Cutaneous Melanoma: A Population-Based Study in New South Wales, Australia

  2018cites this paper
• Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients

  2017cites this paper
• Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients

  2017cites this paper
• Factors Linked to the Metastatic Spread of Malignant Cutaneous Melanoma to the Lower Extremities in a Retrospective 18F-FDG PET/CT Cohort

  2017cites this paper
• SEOM clinical guideline for the management of malignant melanoma (2017)

  2017cites this paper
• Conditional Survival-Based “Abbreviated” Routine Cancer Surveillance for Pathologic Stage IB Melanoma

  2017cites this paper
• Screening for Recurrence and Secondary Cancers.

  2017cites this paper
• Review of guidance on recurrence risk management for general practitioners in breast cancer, colorectal cancer and melanoma guidelines

  2017cites this paper
• Prognostic risk factors of first recurrence in patients with primary stages I–II cutaneous malignant melanoma – from the population‐based Swedish melanoma register

  2017cites this paper
• The role of the ugly duckling sign in patient education

  2017cites this paper
• Patient Symptoms Are the Most Frequent Indicators of Recurrence in Patients with American Joint Committee on Cancer Stage II Melanoma.

  2017cites this paper
• A case of lymph node metastasis from auricular squamous cell carcinoma that occurred seven years after surgery

  2016cites this paper
• Commentary: Improved patient outcomes remain elusive after intensive imaging surveillance for high-risk melanoma.

  2016cites this paper
• Optimal scheduling of post-therapeutic follow-up of patients treated for cancer for early detection of relapses

  2016cites this paper
• Skin Examination Practices Among Melanoma Survivors and Their Children

  2016cites this paper
• Comment on: "Risk of subsequent melanoma after melanoma in situ and invasive melanoma: A population-based study from 1973 to 2011".

  2016cites this paper
• Skin self-examination behaviors among individuals diagnosed with melanoma

  2016cites this paper
• Total Body Photography as an Aid to Skin Self-examination: A Patient's Perspective.

  2016cites this paper
• A prospective population-based study, aiming to support decision-making in a follow-up programme for patients with cutaneous malignant melanoma, based on patterns of recurrence

  2016cites this paper
• The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients—Results after 1 Year

  2016cites this paper
• Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study.

  2016cites this paper
• Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal study.

  2015cites this paper
• How Often Do Patients with Localized Melanoma Attend Follow-Up at a Specialist Center?

  2015cites this paper
• Actual practice of melanoma follow‐up and treatment in Germany: results of a prospective, longitudinal cohort study

  2015cites this paper
• Coping with melanoma-related worry: a qualitative study of the experiences and support needs of patients with malignant melanoma.

  2015cites this paper
• SEOM guidelines for the management of Malignant Melanoma 2015

  2015cites this paper
• Clinical practice guidelines for identification, screening and follow‐up of individuals at high risk of primary cutaneous melanoma: a systematic review

  2015cites this paper
• Doctor, your next patient is the rabbit in room 7.

  2014cites this paper
• Follow-up in melanoma patients

  2014cites this paper
• Melanoom: chirurgische behandeling

  2014cites this paper
• Intensity of Follow-Up After Melanoma Surgery

  2014cites this paper
• Cutaneous melanoma: medical specialists' opinions on follow-up and sentinel lymph node biopsy.

  2014cites this paper
• Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.

  2014cites this paper
• Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence.

  2014cites this paper
• Badania kontrolne po leczeniu w najczęstszych nowotworach litych

  2014cites this paper
• Follow-up of cutaneous melanoma patients: a proposal for standardization.

  2014cites this paper
• Evidence-based guidelines to determine follow-up intervals: a call for action.

  2014cites this paper
• Post-treatment surveillance in most common solid malignancies in adults

  2014cites this paper
• Estadificación y seguimiento de los pacientes con melanoma: ¿qué exploraciones y a qué pacientes?

  2014cites this paper
• Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review

  2014cites this paper
• Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.

  2014cites this paper
• Simultaneous Breast and Axillary Recurrence in a Patient with a History of Breast Cancer and Ipsilateral Upper Extremity Melanoma: Challenges in Diagnosis and Management

  2014cites this paper
• Staging and follow-up of patients with melanoma: which tests for which patients?

  2014cites this paper
• Staging and Follow-Up of Patients With Melanoma: Which Tests for Which Patients?

  2014cites this paper
• Follow-up in patients with low-risk cutaneous melanoma: is it worth it?

  2014cites this paper
• Cutaneous Melanoma Surveillance Counterpoint: Australia

  2013cites this paper
• Advances in skin cancer early detection and diagnosis.

  2013cites this paper
• Psychosocial aspects of post‐treatment follow‐up for stage I/II melanoma: a systematic review of the literature

  2013cites this paper
• Barriers and facilitators of adherence to medical advice on skin self-examination during melanoma follow-up care

  2013cites this paper
• Trends in the risks of melanoma as a second primary cancer among cancer patients in the Netherlands, 1989–2008

  2013cites this paper
• Follow‐up of early stage melanoma: Specialist clinician perspectives on the functions of follow‐up and implications for extending follow‐up intervals

  2013cites this paper
• Melanoma patient self-detection: a review of efficacy of the skin self-examination and patient-directed educational efforts

  2013cites this paper
• Skin Cancer Screening

  2013cites this paper
• Hazard-Rate Analysis and Patterns of Recurrence in Early Stage Melanoma: Moving towards a Rationally Designed Surveillance Strategy

  2013cites this paper
• The identification of diagnostic serological autoantibodies for Cutaneous Melanoma

  2013cites this paper
• Cutaneous melanoma surveillance counterpoint: USA

  2013cites this paper
• Prävention von Hauttumoren

  2013cites this paper
• Chirurgische behandeling melanomen

  2013cites this paper
• Progression in melanoma

  2013cites this paper
• Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”

  2013cites this paper